Gastrointestinal Cancer

The Pharmacy Times® Gastrointestinal Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that occur in digestive tract organs, such as the stomach, large and small intestine, pancreas, colon, liver, rectum, anus, and biliary system.

Latest News

OPC 2025: Early and Metastatic GI Cancers See Practice-Changing Trial Results
OPC 2025: Early and Metastatic GI Cancers See Practice-Changing Trial Results

June 20th 2025

At the 2025 Oncology Pharmacists Connect (OPC) meeting, Courtney Cavalieri, PharmD, BCOP, presented clinical trial findings in gastrointestinal (GI) cancers—including colon, gastric, pancreatic, and metastatic colorectal cancer—that highlight the expanding role of immunotherapy and targeted treatments.

FDA approval seal -- Image credit: Aquir | stock.adobe.com
Retifanlimab-Dlwr Becomes First and Only FDA-Approved First-Line Treatment for Advanced Anal Cancer

May 15th 2025

Biliary tract cancer (BTC) -- Image credit: Arugula Pica | stock.adobe.com
Zanidatamab Is a Breakthrough in HER2- Positive Biliary Tract Cancer Treatment

April 24th 2025

FDA logo on a smartphone screen -- Image credit: Luciano Luppa | stock.adobe.com
FDA Approves Nivolumab With Ipilimumab for First-Line Treatment of Adult Patients With HCC

April 11th 2025

Video Interviews
Podcasts

More News